136 related articles for article (PubMed ID: 23958903)
1. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
Yoshitomi T; Nagasaki Y
Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
[TBL] [Abstract][Full Text] [Related]
3. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
Yoshitomi T; Hirayama A; Nagasaki Y
Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
[TBL] [Abstract][Full Text] [Related]
4. Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
Vong LB; Yoshitomi T; Matsui H; Nagasaki Y
Biomaterials; 2015 Jul; 55():54-63. PubMed ID: 25934452
[TBL] [Abstract][Full Text] [Related]
5. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Vong LB; Nagasaki Y
Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
[TBL] [Abstract][Full Text] [Related]
6. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
[TBL] [Abstract][Full Text] [Related]
7. Novel neuroprotection using antioxidant nanoparticles in a mouse model of head trauma.
Takahashi T; Marushima A; Nagasaki Y; Hirayama A; Muroi A; Puentes S; Mujagic A; Ishikawa E; Matsumura A
J Trauma Acute Care Surg; 2020 May; 88(5):677-685. PubMed ID: 32039974
[TBL] [Abstract][Full Text] [Related]
8. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
9. Redox-active injectable gel using thermo-responsive nanoscale polyion complex flower micelle for noninvasive treatment of local inflammation.
Pua ML; Yoshitomi T; Chonpathompikunlert P; Hirayama A; Nagasaki Y
J Control Release; 2013 Dec; 172(3):914-20. PubMed ID: 24157475
[TBL] [Abstract][Full Text] [Related]
10. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice.
Feliciano CP; Tsuboi K; Suzuki K; Kimura H; Nagasaki Y
Biomaterials; 2017 Jun; 129():68-82. PubMed ID: 28324866
[TBL] [Abstract][Full Text] [Related]
11. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer.
Shashni B; Nagasaki Y
Biomaterials; 2018 Sep; 178():48-62. PubMed ID: 29908344
[TBL] [Abstract][Full Text] [Related]
12. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects.
Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W
Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
15. Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Hossain MA; Yamashita M; Vong LB; Ikeda Y; Nagasaki Y
J Drug Target; 2014 Aug; 22(7):638-47. PubMed ID: 24955616
[TBL] [Abstract][Full Text] [Related]
16. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
Han L; Tang C; Yin C
Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
[TBL] [Abstract][Full Text] [Related]
17. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
18. [Design of New Cancer Nanotherapeutics Which Controls Active Gaseous Molecules in Vivo].
Nagasaki Y
Yakugaku Zasshi; 2018; 138(7):911-918. PubMed ID: 29962468
[TBL] [Abstract][Full Text] [Related]
19. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
Vong LB; Tomita T; Yoshitomi T; Matsui H; Nagasaki Y
Gastroenterology; 2012 Oct; 143(4):1027-36.e3. PubMed ID: 22771506
[TBL] [Abstract][Full Text] [Related]
20. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
